Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Brescia
Clinical trial register · Italy

Clinical Trials in Brescia, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Bologna 11 Florence 11 Brescia 8 Bari 8 Ancona 7
Narrow the registerReset
Recruitment status
Phase
Site location
Bologna11 Florence11 Brescia8 Bari8 Ancona7
All 44 locations
Target enrolment
to

Trials with a site in Brescia

8 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
100
Ancona, Bergamo, Bologna, Brescia, Candiolo, Florence, Milan, Naples
2024-11-01
Active, closed
Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients
NCT05306301Chemotherapy, Leukemia, Acute Lymphoblastic
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
32
Avellino, Pagani, Bergamo, Bologna, Brescia, Catania, Florence, Lecce
2022-10-05
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
101
Alessandria, Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Castelfranco Veneto
2021-12-03
Recruiting
Study on the Diagnosis and Management of CLL in Italy by GIMEMA
NCT04867915Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, MBL-CLL - Monoclonal B-Cell Lymphocytosis Chronic Lymphocytic Leukaemia-Type
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
12,500
Alessandria, Brescia, Brindisi, Candiolo, Florence, Messina, Mestre, Milan
2021-10-13
Active, closed
Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL
NCT04722848Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), ALL, Adult, Philadelphia-Positive ALL
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3
236
Ascoli Piceno, Bari, Bergamo, Bolzano, Brescia, Mestre, Modena, Pagani
2021-09-08
Active, closed
Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse
NCT04475731Philadelphia-Positive ALL, Acute Lymphoblastic Leukemia, in Relapse
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
67
Ancona, Ascoli Piceno, Avellino, Bari, Bergamo, Bologna, Brescia, Cuneo
2021-05-04
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3
274
Alessandria, Ancona, Ascoli Piceno, Bari, Bologna, Brescia, Brindisi, Castelfranco Veneto
2020-11-27
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
76
Ancona, Ascoli Piceno, Bergamo, Bologna, Bolzano, Brescia, Cuneo, Genova
2019-10-30
Rows per page Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/brescia

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 8 of those studies with a site in Brescia that also match the filters currently applied.

How many clinical trials are recruiting in Brescia?

3 of the 8 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Brescia), 8 studies
PhaseStudiesRecruitingShare
Phase 24050%
Observational2225%
Phase 32125%

Most active sponsors

Lead sponsors with the most studies (Brescia)
Lead sponsorStudiesRecruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto83
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.